Literature DB >> 21849433

Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection.

Anna Haas1, Kathrin Zimmermann, Annette Oxenius.   

Abstract

Continuous loss of CD4(+) T lymphocytes and systemic immune activation are hallmarks of untreated chronic HIV-1 infection. Chronic immune activation during HIV-1 infection is characterized by increased expression of activation markers on T cells, elevated levels of proinflammatory cytokines, and B cell hyperactivation together with hypergammaglobulinemia. Importantly, hyperactivation of T cells is one of the best predictive markers for progression toward AIDS, and it is closely linked to CD4(+) T cell depletion and sustained viral replication. Aberrant activation of T cells is observed mainly for memory CD4(+) and CD8(+) T cells and is documented, in addition to increased expression of surface activation markers, by increased cell cycling and apoptosis. Notably, the majority of these activated T cells are neither HIV specific nor HIV infected, and the antigen specificities of hyperactivated T cells are largely unknown, as are the exact mechanisms driving their activation. B cells are also severely affected by HIV-1 infection, which is manifested by major changes in B cell subpopulations, B cell hyperactivation, and hypergammaglobulinemia. Similar to those of T cells, the mechanisms underlying this aberrant B cell activation remain largely unknown. In this review, we summarized current knowledge about proposed antigen-dependent and -independent mechanisms leading to lymphocyte hyperactivation in the context of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849433      PMCID: PMC3209369          DOI: 10.1128/JVI.05607-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  157 in total

Review 1.  Lymphocyte life-span and memory.

Authors:  J Sprent; D F Tough
Journal:  Science       Date:  1994-09-02       Impact factor: 47.728

2.  Immunoglobulin VH3 gene products: natural ligands for HIV gp120.

Authors:  L Berberian; L Goodglick; T J Kipps; J Braun
Journal:  Science       Date:  1993-09-17       Impact factor: 47.728

3.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.

Authors:  J Embretson; M Zupancic; J L Ribas; A Burke; P Racz; K Tenner-Racz; A T Haase
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

4.  Prognostic value of serum immunoglobulin A antibodies to pol gene products during HIV-1 infection.

Authors:  A Quesnel; B Pozzetto; P Moja; F Grattard; F R Lucht; J L Touraine; O G Gaudin; C Genin
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

5.  Nef protein of HIV-1 has B-cell stimulatory activity.

Authors:  N Chirmule; N Oyaizu; C Saxinger; S Pahwa
Journal:  AIDS       Date:  1994-06       Impact factor: 4.177

6.  Serum antibodies to viral pathogens and Toxoplasma gondii in HIV-infected individuals.

Authors:  R W Flø; A Nilsen; P Voltersvik; G Haukenes
Journal:  APMIS       Date:  1993-12       Impact factor: 3.205

7.  Costimulatory properties of the human CD4 molecule: enhancement of CD3-induced T cell activation by human immunodeficiency virus type 1 through viral envelope glycoprotein gp120.

Authors:  T Oravecz; M A Norcross
Journal:  AIDS Res Hum Retroviruses       Date:  1993-10       Impact factor: 2.205

8.  Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation.

Authors:  A Shirai; M Cosentino; S F Leitman-Klinman; D M Klinman
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

9.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

Authors:  D D Ho; A U Neumann; A S Perelson; W Chen; J M Leonard; M Markowitz
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

10.  Antigen-independent activation of naive and memory resting T cells by a cytokine combination.

Authors:  D Unutmaz; P Pileri; S Abrignani
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  49 in total

Review 1.  Tuberculosis and HIV Coinfection.

Authors:  Judith Bruchfeld; Margarida Correia-Neves; Gunilla Källenius
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-26       Impact factor: 6.915

2.  HIV-1 infection ex vivo accelerates measles virus infection by upregulating signaling lymphocytic activation molecule (SLAM) in CD4+ T cells.

Authors:  Yu-ya Mitsuki; Kazutaka Terahara; Kentaro Shibusawa; Takuya Yamamoto; Takatsugu Tsuchiya; Fuminori Mizukoshi; Masayuki Ishige; Seiji Okada; Kazuo Kobayashi; Yuko Morikawa; Tetsuo Nakayama; Makoto Takeda; Yusuke Yanagi; Yasuko Tsunetsugu-Yokota
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Effective B cell activation in vitro during viremic HIV-1 infection with surrogate T cell stimulation.

Authors:  Lindsay K Nicholson; Harsh Pratap; Elisabeth Bowers; Elise Gunzburger; Srinivasa R Bandi; Edward M Gardner; Brent E Palmer; Timothy Wright; John Kittelson; Edward N Janoff
Journal:  Immunobiology       Date:  2018-09-07       Impact factor: 3.144

4.  Impact of CD4+ lymphocytes and HIV infection on Anti-Müllerian Hormone levels in a large cohort of HIV-infected and HIV-uninfected women.

Authors:  Rebecca Scherzer; Peter Bacchetti; Geralyn Messerlian; Johanna Goderre; Pauline M Maki; David B Seifer; Kathryn Anastos; Roksana Karim; Ruth M Greenblatt
Journal:  Am J Reprod Immunol       Date:  2014-10-23       Impact factor: 3.886

Review 5.  Potential implication of residual viremia in patients on effective antiretroviral therapy.

Authors:  Gautam K Sahu
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

6.  mTOR signaling mediates effects of common gamma-chain cytokines on T cell proliferation and exhaustion: implications for HIV-1 persistence and cure research.

Authors:  Harry E Taylor; Nina A Calantone; Richard T D'Aquila
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

7.  Single-cell mass cytometry analysis of human tonsil T cell remodeling by varicella zoster virus.

Authors:  Nandini Sen; Gourab Mukherjee; Adrish Sen; Sean C Bendall; Phillip Sung; Garry P Nolan; Ann M Arvin
Journal:  Cell Rep       Date:  2014-07-17       Impact factor: 9.423

8.  Immune complexes that contain HIV antigens activate peripheral blood T cells.

Authors:  L B Korolevskaya; K V Shmagel; E V Saidakova; N G Shmagel; V A Chereshnev
Journal:  Dokl Biol Sci       Date:  2016-09-07

Review 9.  T cell exhaustion during persistent viral infections.

Authors:  Shannon M Kahan; E John Wherry; Allan J Zajac
Journal:  Virology       Date:  2015-01-22       Impact factor: 3.616

10.  LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

Authors:  Shi-Dong Ma; Xuequn Xu; Julie Plowshay; Erik A Ranheim; William J Burlingham; Jeffrey L Jensen; Fotis Asimakopoulos; Weihua Tang; Margaret L Gulley; Ethel Cesarman; Jenny E Gumperz; Shannon C Kenney
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.